ѻý

Devices Flop for Severe PAD; CPR on LVAD Patients; Cancer Drugs for Heart Disease?

<ѻý class="mpt-content-deck">— Recent developments of interest in cardiovascular medicine
MedpageToday
Cardio Break over a computer rendering of a heart.

For patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia, drug-eluting stents and drug-coated balloons compared with balloon angioplasty alone in the BASIL-3 trial. (TCTMD)

The American College of Cardiology announced that a 90-day comment period is now open for the new . The first 10 directors have been selected.

The American Heart Association applauded the Department of Agriculture's move to , but called out the lack of restrictions on sugary cereals and donuts.

Heart failure mortality is now . (JAMA Cardiology)

Chest compressions did not appear to hurt patients with a (LVAD), nor did they dislodge devices. (JACC: Heart Failure)

Could niraparib (Zejula) and other anti-cancer drugs counteract the ? (Circulation)

Penumbra announced the FDA clearance and launch of , a computer-assisted vacuum thrombectomy system for removing venous thrombus and treating pulmonary emboli.

Major cardiovascular trials often have , a systematic review showed. (JAMA Network Open)

share genes and possible development pathways. (Frontiers in Psychiatry)

have a joint impact on death from cardiovascular disease, according to research highlighted by the European Society of Cardiology (ESC).

The ESC also pointed to research that showed that women with heart disease are .

Poor cardiovascular health in midlife was linked to in Black women. (Journal of the American Heart Association)

Nearly half of men ages 20-44 are believed to have stage 2 or worse in the U.S. (Journal of the American College of Cardiology)

in the "high-normal" range predicted an elevated risk of incident atrial fibrillation in healthy older men. (eClinicalMedicine)

Women diagnosed with may be a higher-risk group who would benefit from intensive blood pressure treatment. (Diabetes Care)

In patients with T2D and stage 5 chronic kidney disease, use of was linked to reduced risks for dialysis and cardiovascular events, an emulated target trial showed. (Annals of Internal Medicine)

New were launched by the Society of Thoracic Surgeons.

People with , the rare growth hormone receptor deficiency, have particularly good longevity and heart disease risk factor levels. (Med)

The U.S. Preventive Services Task Force released a draft research plan on the use of for enhanced cardiovascular disease risk assessment.

Weis Markets stores in Maryland will be equipped with ahead of the state's 2025 deadline for the requirement of such devices in grocery stores and restaurants. (WMAR)

  • author['full_name']

    Nicole Lou is a reporter for ѻý, where she covers cardiology news and other developments in medicine.